CYP19A1 and polycystic ovary syndrome: Reduced aromatase activity causes hindrance in the transformationof androgen to estrogen, contributing to androgen excess in the ovaries.Consequently, elevated levels of androgen continue to ensure the suppressionof aromatase activity.5Figure 1 explains the pathogenesisof PCOS.